Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Medpace management to meet virtually with Truist » 04:55
05/20/21
05/20
04:55
05/20/21
04:55
MEDP

Medpace

$164.00 /

+1.42 (+0.87%)

Virtual Meeting to be…

Virtual Meeting to be held on May 20 hosted by Truist.

ShowHide Related Items >><<
MEDP Medpace
$164.00 /

+1.42 (+0.87%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
MEDP Medpace
$164.00 /

+1.42 (+0.87%)

Conference/Events
Medpace management to meet virtually with Truist » 11:00
05/14/21
05/14
11:00
05/14/21
11:00
MEDP

Medpace

$164.65 /

+4.59 (+2.87%)

Virtual Meeting to be…

Virtual Meeting to be held on May 20 hosted by Truist.

ShowHide Related Items >><<
MEDP Medpace
$164.65 /

+4.59 (+2.87%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
MEDP Medpace
$164.65 /

+4.59 (+2.87%)

Over a month ago
Earnings
Medpace raises FY21 EPS view to $4.24-$4.42 from $4.08-$4.50 » 16:21
04/26/21
04/26
16:21
04/26/21
16:21
MEDP

Medpace

$194.58 /

+3.4 (+1.78%)

Consensus $4.37. Raises…

Consensus $4.37. Raises FY21 revenue view to $1.09B-$1.15B from $1.075B-$1.175B, consensus $1.14B.

ShowHide Related Items >><<
MEDP Medpace
$194.58 /

+3.4 (+1.78%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
MEDP Medpace
$194.58 /

+3.4 (+1.78%)

Earnings
Medpace reports Q1 EPS $1.14, consensus $1.00 » 16:17
04/26/21
04/26
16:17
04/26/21
16:17
MEDP

Medpace

$194.58 /

+3.4 (+1.78%)

Reports Q1 revenue $260M,…

Reports Q1 revenue $260M, consensus $265.28M.

ShowHide Related Items >><<
MEDP Medpace
$194.58 /

+3.4 (+1.78%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
MEDP Medpace
$194.58 /

+3.4 (+1.78%)

Conference/Events
Society for Clinical Research Sites to hold a virtual summit Vertex Pharmaceuticals » 04:55
04/22/21
04/22
04:55
04/22/21
04:55
ABBV

AbbVie

$110.81 /

+1.78 (+1.63%)

, AMGN

Amgen

$258.70 /

-0.4 (-0.15%)

, AZN

AstraZeneca

$53.11 /

+0.84 (+1.61%)

, BAYRY

Bayer

$16.90 /

+0.55 (+3.36%)

, CPI

Capital Properties

$27.28 /

+ (+0.00%)

, GSK

GlaxoSmithKline

$38.25 /

+0.535 (+1.42%)

, ICLR

Icon

$210.78 /

+4.21 (+2.04%)

, IQV

Iqvia

$219.08 /

+2 (+0.92%)

, LLY

Eli Lilly

$191.00 /

+0.45 (+0.24%)

, MDT

Medtronic

$130.19 /

+1.9 (+1.48%)

, MEDP

Medpace

$188.28 /

+3.84 (+2.08%)

, MRK

Merck

$79.24 /

+0.67 (+0.85%)

, NOV

NOV Inc.

$13.08 /

+0.33 (+2.59%)

, NVS

Novartis

$88.67 /

+0.84 (+0.96%)

, PPD

PPD

$46.16 /

-0.095 (-0.21%)

, RHHBY

Roche

$43.19 /

+1.17 (+2.78%)

, SNY

Sanofi

$52.43 /

+0.44 (+0.85%)

, SYNH

Syneos Health

$87.89 /

+2.59 (+3.04%)

, VRTX

Vertex Pharmaceuticals

$219.79 /

-0.23 (-0.10%)

European Site Solutions…

European Site Solutions Virtual Summit will be held on April 20-22. Webcast Link

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$219.79 /

-0.23 (-0.10%)

SYNH Syneos Health
$87.89 /

+2.59 (+3.04%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

RHHBY Roche
$43.19 /

+1.17 (+2.78%)

PPD PPD
$46.16 /

-0.095 (-0.21%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

NOV NOV Inc.
$13.08 /

+0.33 (+2.59%)

MRK Merck
$79.24 /

+0.67 (+0.85%)

MDT Medtronic
$130.19 /

+1.9 (+1.48%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

IQV Iqvia
$219.08 /

+2 (+0.92%)

ICLR Icon
$210.78 /

+4.21 (+2.04%)

GSK GlaxoSmithKline
$38.25 /

+0.535 (+1.42%)

BAYRY Bayer
$16.90 /

+0.55 (+3.36%)

AZN AstraZeneca
$53.11 /

+0.84 (+1.61%)

AMGN Amgen
$258.70 /

-0.4 (-0.15%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day positive catalyst' on AbbVie, reiterates Buy rating
04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
AMGN Amgen
$258.70 /

-0.4 (-0.15%)

04/05/21 Oppenheimer
Amgen price target raised to $275 from $266 at Oppenheimer
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/08/21 Guggenheim
Five Prime downgraded to Neutral from Buy at Guggenheim
03/05/21 Barclays
Amgen price target lowered to $230 from $242 at Barclays
AZN AstraZeneca
$53.11 /

+0.84 (+1.61%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/12/21 Argus
AstraZeneca downgraded to Hold from Buy at Argus
BAYRY Bayer
$16.90 /

+0.55 (+3.36%)

03/19/21 Deutsche Bank
Bayer price target raised to EUR 66 from EUR 63 at Deutsche Bank
03/11/21 Societe Generale
Bayer price target lowered to EUR 59 from EUR 68 at Societe Generale
03/03/21 Berenberg
Bayer price target raised to EUR 68 from EUR 60 at Berenberg
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
CPI Capital Properties
$27.28 /

+ (+0.00%)

GSK GlaxoSmithKline
$38.25 /

+0.535 (+1.42%)

04/20/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
04/20/21 UBS
GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
04/20/21 Citi
GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi
03/23/21
Fly Intel: Top five analyst downgrades
ICLR Icon
$210.78 /

+4.21 (+2.04%)

04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
04/13/21 BofA
Icon resumed with a Neutral at BofA
04/01/21 Wells Fargo
Icon upgraded to Overweight from Equal Weight at Wells Fargo
04/01/21 Wells Fargo
Icon upgraded to Overweight from Equal Weight at Wells Fargo
IQV Iqvia
$219.08 /

+2 (+0.92%)

04/16/21
Fly Intel: Top five analyst upgrades
04/16/21 Stephens
Iqvia upgraded to Overweight with $250 price target at Stephens
04/16/21 Stephens
Iqvia upgraded to Overweight from Equal Weight at Stephens
04/09/21 Mizuho
Iqvia price target raised to $218 from $210 at Mizuho
LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$130.19 /

+1.9 (+1.48%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
MEDP Medpace
$188.28 /

+3.84 (+2.08%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
MRK Merck
$79.24 /

+0.67 (+0.85%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
04/08/21 Alliance Global Partners
Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
NOV NOV Inc.
$13.08 /

+0.33 (+2.59%)

01/21/21 Susquehanna
NOV Inc. price target lowered to $17 from $18 at Susquehanna
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/12/21 Citi
NOV Inc. upgraded to Buy from Neutral at Citi
NVS Novartis
$88.67 /

+0.84 (+0.96%)

04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
PPD PPD
$46.16 /

-0.095 (-0.21%)

04/20/21 Jefferies
PPD downgraded to Hold from Buy at Jefferies
04/19/21
Fly Intel: Top five analyst downgrades
04/19/21 Citi
PPD downgraded to Neutral from Buy at Citi
04/19/21 Mizuho
PPD downgraded to Neutral from Buy at Mizuho
RHHBY Roche
$43.19 /

+1.17 (+2.78%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
SNY Sanofi
$52.43 /

+0.44 (+0.85%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SYNH Syneos Health
$87.89 /

+2.59 (+3.04%)

03/02/21 Barclays
Syneos Health initiated with an Equal Weight at Barclays
03/02/21 Barclays
Syneos Health initiated with an Equal Weight at Barclays
02/22/21 Mizuho
Syneos Health price target raised to $87 from $72 at Mizuho
02/19/21 Citi
Syneos Health price target raised to $85 from $80 at Citi
VRTX Vertex Pharmaceuticals
$219.79 /

-0.23 (-0.10%)

04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/20/21 Chardan
Amended pact may show Vertex confidence in Crisper program, says Chardan
03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
VRTX Vertex Pharmaceuticals
$219.79 /

-0.23 (-0.10%)

SYNH Syneos Health
$87.89 /

+2.59 (+3.04%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

RHHBY Roche
$43.19 /

+1.17 (+2.78%)

PPD PPD
$46.16 /

-0.095 (-0.21%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

NOV NOV Inc.
$13.08 /

+0.33 (+2.59%)

MRK Merck
$79.24 /

+0.67 (+0.85%)

MEDP Medpace
$188.28 /

+3.84 (+2.08%)

MDT Medtronic
$130.19 /

+1.9 (+1.48%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

IQV Iqvia
$219.08 /

+2 (+0.92%)

ICLR Icon
$210.78 /

+4.21 (+2.04%)

GSK GlaxoSmithKline
$38.25 /

+0.535 (+1.42%)

BAYRY Bayer
$16.90 /

+0.55 (+3.36%)

AZN AstraZeneca
$53.11 /

+0.84 (+1.61%)

AMGN Amgen
$258.70 /

-0.4 (-0.15%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

  • 01
    Mar
  • 02
    Dec
  • 16
    Sep
  • 17
    Sep
VRTX Vertex Pharmaceuticals
$219.79 /

-0.23 (-0.10%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

RHHBY Roche
$43.19 /

+1.17 (+2.78%)

PPD PPD
$46.16 /

-0.095 (-0.21%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

MRK Merck
$79.24 /

+0.67 (+0.85%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

ICLR Icon
$210.78 /

+4.21 (+2.04%)

GSK GlaxoSmithKline
$38.25 /

+0.535 (+1.42%)

BAYRY Bayer
$16.90 /

+0.55 (+3.36%)

AZN AstraZeneca
$53.11 /

+0.84 (+1.61%)

AMGN Amgen
$258.70 /

-0.4 (-0.15%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

VRTX Vertex Pharmaceuticals
$219.79 /

-0.23 (-0.10%)

SNY Sanofi
$52.43 /

+0.44 (+0.85%)

RHHBY Roche
$43.19 /

+1.17 (+2.78%)

PPD PPD
$46.16 /

-0.095 (-0.21%)

NVS Novartis
$88.67 /

+0.84 (+0.96%)

NOV NOV Inc.
$13.08 /

+0.33 (+2.59%)

MRK Merck
$79.24 /

+0.67 (+0.85%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

IQV Iqvia
$219.08 /

+2 (+0.92%)

ICLR Icon
$210.78 /

+4.21 (+2.04%)

GSK GlaxoSmithKline
$38.25 /

+0.535 (+1.42%)

BAYRY Bayer
$16.90 /

+0.55 (+3.36%)

AZN AstraZeneca
$53.11 /

+0.84 (+1.61%)

AMGN Amgen
$258.70 /

-0.4 (-0.15%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

VRTX Vertex Pharmaceuticals
$219.79 /

-0.23 (-0.10%)

NOV NOV Inc.
$13.08 /

+0.33 (+2.59%)

MRK Merck
$79.24 /

+0.67 (+0.85%)

MDT Medtronic
$130.19 /

+1.9 (+1.48%)

LLY Eli Lilly
$191.00 /

+0.45 (+0.24%)

IQV Iqvia
$219.08 /

+2 (+0.92%)

GSK GlaxoSmithKline
$38.25 /

+0.535 (+1.42%)

AZN AstraZeneca
$53.11 /

+0.84 (+1.61%)

AMGN Amgen
$258.70 /

-0.4 (-0.15%)

ABBV AbbVie
$110.81 /

+1.78 (+1.63%)

Conference/Events
Society for Clinical Research Sites to hold a virtual summit Vertex Pharmaceuticals » 09:55
04/21/21
04/21
09:55
04/21/21
09:55
ABBV

AbbVie

$110.77 /

+1.74 (+1.60%)

, AMGN

Amgen

$259.77 /

+0.67 (+0.26%)

, AZN

AstraZeneca

$52.80 /

+0.53 (+1.01%)

, BAYRY

Bayer

$16.35 /

-0.24 (-1.45%)

, CPI

Capital Properties

$27.28 /

+ (+0.00%)

, GSK

GlaxoSmithKline

$38.06 /

+0.35 (+0.93%)

, ICLR

Icon

$206.49 /

-0.08 (-0.04%)

, IQV

Iqvia

$215.69 /

-1.39 (-0.64%)

, LLY

Eli Lilly

$191.76 /

+1.21 (+0.64%)

, MDT

Medtronic

$128.91 /

+0.62 (+0.48%)

, MEDP

Medpace

$184.51 /

+0.07 (+0.04%)

, MRK

Merck

$78.85 /

+0.28 (+0.36%)

, NOV

NOV Inc.

$12.66 /

-0.09 (-0.71%)

, NVS

Novartis

$88.47 /

+0.64 (+0.73%)

, PPD

PPD

$46.28 /

+0.03 (+0.06%)

, RHHBY

Roche

$42.02 /

-0.26 (-0.61%)

, SNY

Sanofi

$52.31 /

+0.32 (+0.62%)

, SYNH

Syneos Health

$85.29 /

-0.01 (-0.01%)

, VRTX

Vertex Pharmaceuticals

$219.75 /

-0.27 (-0.12%)

European Site Solutions…

European Site Solutions Virtual Summit will be held on April 20-22. Webcast Link

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$219.75 /

-0.27 (-0.12%)

SYNH Syneos Health
$85.29 /

-0.01 (-0.01%)

SNY Sanofi
$52.31 /

+0.32 (+0.62%)

RHHBY Roche
$42.02 /

-0.26 (-0.61%)

PPD PPD
$46.28 /

+0.03 (+0.06%)

NVS Novartis
$88.47 /

+0.64 (+0.73%)

NOV NOV Inc.
$12.66 /

-0.09 (-0.71%)

MRK Merck
$78.85 /

+0.28 (+0.36%)

MDT Medtronic
$128.91 /

+0.62 (+0.48%)

LLY Eli Lilly
$191.76 /

+1.21 (+0.64%)

IQV Iqvia
$215.69 /

-1.39 (-0.64%)

ICLR Icon
$206.49 /

-0.08 (-0.04%)

GSK GlaxoSmithKline
$38.06 /

+0.35 (+0.93%)

BAYRY Bayer
$16.35 /

-0.24 (-1.45%)

AZN AstraZeneca
$52.80 /

+0.53 (+1.01%)

AMGN Amgen
$259.77 /

+0.67 (+0.26%)

ABBV AbbVie
$110.77 /

+1.74 (+1.60%)

ABBV AbbVie
$110.77 /

+1.74 (+1.60%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day positive catalyst' on AbbVie, reiterates Buy rating
04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
AMGN Amgen
$259.77 /

+0.67 (+0.26%)

04/05/21 Oppenheimer
Amgen price target raised to $275 from $266 at Oppenheimer
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/08/21 Guggenheim
Five Prime downgraded to Neutral from Buy at Guggenheim
03/05/21 Barclays
Amgen price target lowered to $230 from $242 at Barclays
AZN AstraZeneca
$52.80 /

+0.53 (+1.01%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/12/21 Argus
AstraZeneca downgraded to Hold from Buy at Argus
BAYRY Bayer
$16.35 /

-0.24 (-1.45%)

03/19/21 Deutsche Bank
Bayer price target raised to EUR 66 from EUR 63 at Deutsche Bank
03/11/21 Societe Generale
Bayer price target lowered to EUR 59 from EUR 68 at Societe Generale
03/03/21 Berenberg
Bayer price target raised to EUR 68 from EUR 60 at Berenberg
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
CPI Capital Properties
$27.28 /

+ (+0.00%)

GSK GlaxoSmithKline
$38.06 /

+0.35 (+0.93%)

04/20/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
04/20/21 UBS
GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
04/20/21 Citi
GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi
03/23/21
Fly Intel: Top five analyst downgrades
ICLR Icon
$206.49 /

-0.08 (-0.04%)

04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
04/13/21 BofA
Icon resumed with a Neutral at BofA
04/01/21 Wells Fargo
Icon upgraded to Overweight from Equal Weight at Wells Fargo
04/01/21 Wells Fargo
Icon upgraded to Overweight from Equal Weight at Wells Fargo
IQV Iqvia
$215.69 /

-1.39 (-0.64%)

04/16/21
Fly Intel: Top five analyst upgrades
04/16/21 Stephens
Iqvia upgraded to Overweight with $250 price target at Stephens
04/16/21 Stephens
Iqvia upgraded to Overweight from Equal Weight at Stephens
04/09/21 Mizuho
Iqvia price target raised to $218 from $210 at Mizuho
LLY Eli Lilly
$191.76 /

+1.21 (+0.64%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$128.91 /

+0.62 (+0.48%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
MEDP Medpace
$184.51 /

+0.07 (+0.04%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
MRK Merck
$78.85 /

+0.28 (+0.36%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
04/08/21 Alliance Global Partners
Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
NOV NOV Inc.
$12.66 /

-0.09 (-0.71%)

01/21/21 Susquehanna
NOV Inc. price target lowered to $17 from $18 at Susquehanna
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/12/21 Citi
NOV Inc. upgraded to Buy from Neutral at Citi
NVS Novartis
$88.47 /

+0.64 (+0.73%)

04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
PPD PPD
$46.28 /

+0.03 (+0.06%)

04/20/21 Jefferies
PPD downgraded to Hold from Buy at Jefferies
04/19/21
Fly Intel: Top five analyst downgrades
04/19/21 Citi
PPD downgraded to Neutral from Buy at Citi
04/19/21 Mizuho
PPD downgraded to Neutral from Buy at Mizuho
RHHBY Roche
$42.02 /

-0.26 (-0.61%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
SNY Sanofi
$52.31 /

+0.32 (+0.62%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SYNH Syneos Health
$85.29 /

-0.01 (-0.01%)

03/02/21 Barclays
Syneos Health initiated with an Equal Weight at Barclays
03/02/21 Barclays
Syneos Health initiated with an Equal Weight at Barclays
02/22/21 Mizuho
Syneos Health price target raised to $87 from $72 at Mizuho
02/19/21 Citi
Syneos Health price target raised to $85 from $80 at Citi
VRTX Vertex Pharmaceuticals
$219.75 /

-0.27 (-0.12%)

04/21/21 Jefferies
Jefferies upgrades Crispr Therapeutics to Buy after Vertex deal renegotiated
04/21/21 Barclays
Crispr Therapeutics price target raised to $160 from $140 at Barclays
04/20/21 Chardan
Amended pact may show Vertex confidence in Crisper program, says Chardan
03/25/21 Citi
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
VRTX Vertex Pharmaceuticals
$219.75 /

-0.27 (-0.12%)

SYNH Syneos Health
$85.29 /

-0.01 (-0.01%)

SNY Sanofi
$52.31 /

+0.32 (+0.62%)

RHHBY Roche
$42.02 /

-0.26 (-0.61%)

PPD PPD
$46.28 /

+0.03 (+0.06%)

NVS Novartis
$88.47 /

+0.64 (+0.73%)

NOV NOV Inc.
$12.66 /

-0.09 (-0.71%)

MRK Merck
$78.85 /

+0.28 (+0.36%)

MEDP Medpace
$184.51 /

+0.07 (+0.04%)

MDT Medtronic
$128.91 /

+0.62 (+0.48%)

LLY Eli Lilly
$191.76 /

+1.21 (+0.64%)

IQV Iqvia
$215.69 /

-1.39 (-0.64%)

ICLR Icon
$206.49 /

-0.08 (-0.04%)

GSK GlaxoSmithKline
$38.06 /

+0.35 (+0.93%)

BAYRY Bayer
$16.35 /

-0.24 (-1.45%)

AZN AstraZeneca
$52.80 /

+0.53 (+1.01%)

AMGN Amgen
$259.77 /

+0.67 (+0.26%)

ABBV AbbVie
$110.77 /

+1.74 (+1.60%)

  • 01
    Mar
  • 02
    Dec
  • 16
    Sep
  • 17
    Sep
VRTX Vertex Pharmaceuticals
$219.75 /

-0.27 (-0.12%)

SNY Sanofi
$52.31 /

+0.32 (+0.62%)

RHHBY Roche
$42.02 /

-0.26 (-0.61%)

PPD PPD
$46.28 /

+0.03 (+0.06%)

NVS Novartis
$88.47 /

+0.64 (+0.73%)

MRK Merck
$78.85 /

+0.28 (+0.36%)

LLY Eli Lilly
$191.76 /

+1.21 (+0.64%)

ICLR Icon
$206.49 /

-0.08 (-0.04%)

GSK GlaxoSmithKline
$38.06 /

+0.35 (+0.93%)

BAYRY Bayer
$16.35 /

-0.24 (-1.45%)

AZN AstraZeneca
$52.80 /

+0.53 (+1.01%)

AMGN Amgen
$259.77 /

+0.67 (+0.26%)

ABBV AbbVie
$110.77 /

+1.74 (+1.60%)

VRTX Vertex Pharmaceuticals
$219.75 /

-0.27 (-0.12%)

SNY Sanofi
$52.31 /

+0.32 (+0.62%)

RHHBY Roche
$42.02 /

-0.26 (-0.61%)

PPD PPD
$46.28 /

+0.03 (+0.06%)

NVS Novartis
$88.47 /

+0.64 (+0.73%)

NOV NOV Inc.
$12.66 /

-0.09 (-0.71%)

MRK Merck
$78.85 /

+0.28 (+0.36%)

LLY Eli Lilly
$191.76 /

+1.21 (+0.64%)

IQV Iqvia
$215.69 /

-1.39 (-0.64%)

ICLR Icon
$206.49 /

-0.08 (-0.04%)

GSK GlaxoSmithKline
$38.06 /

+0.35 (+0.93%)

BAYRY Bayer
$16.35 /

-0.24 (-1.45%)

AZN AstraZeneca
$52.80 /

+0.53 (+1.01%)

AMGN Amgen
$259.77 /

+0.67 (+0.26%)

ABBV AbbVie
$110.77 /

+1.74 (+1.60%)

VRTX Vertex Pharmaceuticals
$219.75 /

-0.27 (-0.12%)

NOV NOV Inc.
$12.66 /

-0.09 (-0.71%)

MRK Merck
$78.85 /

+0.28 (+0.36%)

MDT Medtronic
$128.91 /

+0.62 (+0.48%)

LLY Eli Lilly
$191.76 /

+1.21 (+0.64%)

IQV Iqvia
$215.69 /

-1.39 (-0.64%)

GSK GlaxoSmithKline
$38.06 /

+0.35 (+0.93%)

AZN AstraZeneca
$52.80 /

+0.53 (+1.01%)

AMGN Amgen
$259.77 /

+0.67 (+0.26%)

ABBV AbbVie
$110.77 /

+1.74 (+1.60%)

Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 04:55
04/09/21
04/09
04:55
04/09/21
04:55
BLUE

Bluebird Bio

$28.86 /

-1.2 (-3.99%)

, GILD

Gilead

$65.03 /

-0.56 (-0.85%)

, TMO

Thermo Fisher

$471.57 /

+5.26 (+1.13%)

, SGTX

Sigilon Therapeutics

$17.81 /

-0.5 (-2.73%)

, ADAP

Adaptimmune

$5.12 /

+0.16 (+3.23%)

, AGTC

Applied Genetic

$4.57 /

+0.115 (+2.58%)

, ATRA

Atara Biotherapeutics

$14.18 /

-0.035 (-0.25%)

, CABA

Cabaletta Bio

$10.77 /

+0.155 (+1.46%)

, FLXN

Flexion

$8.30 /

-0.03 (-0.36%)

, DTIL

Precision BioSciences

$8.94 /

+0.025 (+0.28%)

, DOV

Dover

$138.50 /

-0.465 (-0.33%)

, GNPX

Genprex

$4.88 /

+0.805 (+19.78%)

, DBTX

Decibel Therapeutics

$10.71 /

-0.35 (-3.16%)

, CYRX

Cryoport

$53.88 /

+2.68 (+5.23%)

, GLW

Corning

$44.57 /

+0.27 (+0.61%)

, FTV

Fortive

$70.23 /

-1.16 (-1.62%)

, KRYS

Krystal Biotech

$73.50 /

-0.25 (-0.34%)

, NVO

Novo Nordisk

$69.24 /

+1.375 (+2.03%)

, NVS

Novartis

$87.02 /

+0.705 (+0.82%)

, ORTX

Orchard Therapeutics

$6.96 /

+0.09 (+1.31%)

, MRK

Merck

$75.48 /

-0.65 (-0.85%)

, MEDP

Medpace

$169.50 /

+1.6 (+0.95%)

, IOVA

Iovance Biotherapeutics

$31.30 /

+0.31 (+1.00%)

, FOLD

Amicus

$9.27 /

-0.0999 (-1.07%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

ORTX Orchard Therapeutics
$6.96 /

+0.09 (+1.31%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

KRYS Krystal Biotech
$73.50 /

-0.25 (-0.34%)

IOVA Iovance Biotherapeutics
$31.30 /

+0.31 (+1.00%)

GNPX Genprex
$4.88 /

+0.805 (+19.78%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FTV Fortive
$70.23 /

-1.16 (-1.62%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

FLXN Flexion
$8.30 /

-0.03 (-0.36%)

DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

DOV Dover
$138.50 /

-0.465 (-0.33%)

DBTX Decibel Therapeutics
$10.71 /

-0.35 (-3.16%)

CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

ADAP Adaptimmune
$5.12 /

+0.16 (+3.23%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$65.03 /

-0.56 (-0.85%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$5.12 /

+0.16 (+3.23%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.30 /

-0.03 (-0.36%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

04/06/21 Stifel
Stifel sees Precision BioSciences' CEO transition as 'disconcerting'
02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
DOV Dover
$138.50 /

-0.465 (-0.33%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.88 /

+0.805 (+19.78%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$10.71 /

-0.35 (-3.16%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$44.57 /

+0.27 (+0.61%)

04/07/21 Argus
Corning price target raised to $54 from $42 at Argus
01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
FTV Fortive
$70.23 /

-1.16 (-1.62%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$73.50 /

-0.25 (-0.34%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$87.02 /

+0.705 (+0.82%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$6.96 /

+0.09 (+1.31%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$75.48 /

-0.65 (-0.85%)

04/08/21 Alliance Global Partners
Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
04/08/21 H.C. Wainwright
Alkermes collaboration not as big as investors wanted, says H.C. Wainwright
04/07/21 Mizuho
Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin
04/06/21 RBC Capital
Merck transferred with a Sector Perform at RBC Capital
MEDP Medpace
$169.50 /

+1.6 (+0.95%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.30 /

+0.31 (+1.00%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

ORTX Orchard Therapeutics
$6.96 /

+0.09 (+1.31%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

MEDP Medpace
$169.50 /

+1.6 (+0.95%)

KRYS Krystal Biotech
$73.50 /

-0.25 (-0.34%)

IOVA Iovance Biotherapeutics
$31.30 /

+0.31 (+1.00%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FTV Fortive
$70.23 /

-1.16 (-1.62%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

FLXN Flexion
$8.30 /

-0.03 (-0.36%)

DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

DOV Dover
$138.50 /

-0.465 (-0.33%)

CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

ADAP Adaptimmune
$5.12 /

+0.16 (+3.23%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FTV Fortive
$70.23 /

-1.16 (-1.62%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

DOV Dover
$138.50 /

-0.465 (-0.33%)

DBTX Decibel Therapeutics
$10.71 /

-0.35 (-3.16%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 04:55
04/08/21
04/08
04:55
04/08/21
04:55
BLUE

Bluebird Bio

$30.06 /

-0.1 (-0.33%)

, GILD

Gilead

$65.59 /

-0.67 (-1.01%)

, TMO

Thermo Fisher

$466.27 /

-2.75 (-0.59%)

, SGTX

Sigilon Therapeutics

$18.35 /

-0.64 (-3.37%)

, ADAP

Adaptimmune

$4.96 /

-0.3 (-5.70%)

, AGTC

Applied Genetic

$4.45 /

-0.29 (-6.12%)

, ATRA

Atara Biotherapeutics

$14.22 /

+0.065 (+0.46%)

, CABA

Cabaletta Bio

$10.54 /

-1.02 (-8.82%)

, FLXN

Flexion

$8.34 /

-0.37 (-4.25%)

, DTIL

Precision BioSciences

$8.92 /

-0.34 (-3.67%)

, DOV

Dover

$139.17 /

-0.27 (-0.19%)

, GNPX

Genprex

$4.07 /

-0.23 (-5.35%)

, DBTX

Decibel Therapeutics

$11.06 /

-0.44 (-3.83%)

, CYRX

Cryoport

$51.23 /

-0.27 (-0.52%)

, GLW

Corning

$44.30 /

-0.38 (-0.85%)

, FTV

Fortive

$71.39 /

+0.25 (+0.35%)

, KRYS

Krystal Biotech

$73.72 /

-0.23 (-0.31%)

, NVO

Novo Nordisk

$67.86 /

-0.185 (-0.27%)

, NVS

Novartis

$86.30 /

-0.09 (-0.10%)

, ORTX

Orchard Therapeutics

$6.87 /

-0.22 (-3.10%)

, MRK

Merck

$76.13 /

+0.34 (+0.45%)

, MEDP

Medpace

$167.40 /

-7.13 (-4.09%)

, IOVA

Iovance Biotherapeutics

$31.02 /

-0.98 (-3.06%)

, FOLD

Amicus

$9.37 /

-0.19 (-1.99%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

ORTX Orchard Therapeutics
$6.87 /

-0.22 (-3.10%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

KRYS Krystal Biotech
$73.72 /

-0.23 (-0.31%)

IOVA Iovance Biotherapeutics
$31.02 /

-0.98 (-3.06%)

GNPX Genprex
$4.07 /

-0.23 (-5.35%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FTV Fortive
$71.39 /

+0.25 (+0.35%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

FLXN Flexion
$8.34 /

-0.37 (-4.25%)

DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

DOV Dover
$139.17 /

-0.27 (-0.19%)

DBTX Decibel Therapeutics
$11.06 /

-0.44 (-3.83%)

CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$65.59 /

-0.67 (-1.01%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.34 /

-0.37 (-4.25%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

04/06/21 Stifel
Stifel sees Precision BioSciences' CEO transition as 'disconcerting'
02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
DOV Dover
$139.17 /

-0.27 (-0.19%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.07 /

-0.23 (-5.35%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$11.06 /

-0.44 (-3.83%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$44.30 /

-0.38 (-0.85%)

04/07/21 Argus
Corning price target raised to $54 from $42 at Argus
01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
FTV Fortive
$71.39 /

+0.25 (+0.35%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$73.72 /

-0.23 (-0.31%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$86.30 /

-0.09 (-0.10%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$6.87 /

-0.22 (-3.10%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$76.13 /

+0.34 (+0.45%)

04/07/21 Mizuho
Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin
04/06/21 RBC Capital
Merck transferred with a Sector Perform at RBC Capital
04/01/21 Morgan Stanley
Merck cancer pipeline underappreciated and 'set to flow,' says Morgan Stanley
MEDP Medpace
$167.40 /

-7.13 (-4.09%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.02 /

-0.98 (-3.06%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.37 /

-0.19 (-1.99%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

ORTX Orchard Therapeutics
$6.87 /

-0.22 (-3.10%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

MEDP Medpace
$167.40 /

-7.13 (-4.09%)

KRYS Krystal Biotech
$73.72 /

-0.23 (-0.31%)

IOVA Iovance Biotherapeutics
$31.02 /

-0.98 (-3.06%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FTV Fortive
$71.39 /

+0.25 (+0.35%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

FLXN Flexion
$8.34 /

-0.37 (-4.25%)

DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

DOV Dover
$139.17 /

-0.27 (-0.19%)

CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FTV Fortive
$71.39 /

+0.25 (+0.35%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

DOV Dover
$139.17 /

-0.27 (-0.19%)

DBTX Decibel Therapeutics
$11.06 /

-0.44 (-3.83%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 04:55
04/07/21
04/07
04:55
04/07/21
04:55
BLUE

Bluebird Bio

$30.15 /

-0.95 (-3.05%)

, GILD

Gilead

$66.26 /

-0.09 (-0.14%)

, TMO

Thermo Fisher

$469.09 /

+3.53 (+0.76%)

, SGTX

Sigilon Therapeutics

$19.05 /

-0.965 (-4.82%)

, ADAP

Adaptimmune

$5.26 /

-0.35 (-6.24%)

, AGTC

Applied Genetic

$4.74 /

-0.26 (-5.20%)

, ATRA

Atara Biotherapeutics

$14.15 /

-0.53 (-3.61%)

, CABA

Cabaletta Bio

$11.21 /

-0.4 (-3.45%)

, FLXN

Flexion

$8.71 /

-0.11 (-1.25%)

, DTIL

Precision BioSciences

$9.23 /

-1.24 (-11.84%)

, DOV

Dover

$139.44 /

-0.74 (-0.53%)

, GNPX

Genprex

$4.29 /

+0.06 (+1.42%)

, DBTX

Decibel Therapeutics

$11.48 /

+0.09 (+0.79%)

, CYRX

Cryoport

$51.47 /

+1.1 (+2.18%)

, GLW

Corning

$44.68 /

-0.81 (-1.78%)

, FTV

Fortive

$71.18 /

-0.78 (-1.08%)

, KRYS

Krystal Biotech

$74.13 /

-4.6 (-5.84%)

, NVO

Novo Nordisk

$68.05 /

-0.235 (-0.34%)

, NVS

Novartis

$86.40 /

-0.89 (-1.02%)

, ORTX

Orchard Therapeutics

$7.09 /

-0.14 (-1.94%)

, MRK

Merck

$75.79 /

-1.21 (-1.57%)

, MEDP

Medpace

$171.71 /

+0.78 (+0.46%)

, IOVA

Iovance Biotherapeutics

$31.99 /

-0.16 (-0.50%)

, FOLD

Amicus

$9.56 /

-0.3848 (-3.87%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

ORTX Orchard Therapeutics
$7.09 /

-0.14 (-1.94%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

KRYS Krystal Biotech
$74.13 /

-4.6 (-5.84%)

IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

GNPX Genprex
$4.29 /

+0.06 (+1.42%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FTV Fortive
$71.18 /

-0.78 (-1.08%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

FLXN Flexion
$8.71 /

-0.11 (-1.25%)

DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

DOV Dover
$139.44 /

-0.74 (-0.53%)

DBTX Decibel Therapeutics
$11.48 /

+0.09 (+0.79%)

CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$66.26 /

-0.09 (-0.14%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.71 /

-0.11 (-1.25%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

04/06/21 Stifel
Stifel sees Precision BioSciences' CEO transition as 'disconcerting'
02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
DOV Dover
$139.44 /

-0.74 (-0.53%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.29 /

+0.06 (+1.42%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$11.48 /

+0.09 (+0.79%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$44.68 /

-0.81 (-1.78%)

01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
01/06/21
Fly Intel: Top five analyst initiations
FTV Fortive
$71.18 /

-0.78 (-1.08%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$74.13 /

-4.6 (-5.84%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$86.40 /

-0.89 (-1.02%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$7.09 /

-0.14 (-1.94%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$75.79 /

-1.21 (-1.57%)

04/06/21 RBC Capital
Merck transferred with a Sector Perform at RBC Capital
04/01/21 Morgan Stanley
Merck cancer pipeline underappreciated and 'set to flow,' says Morgan Stanley
03/15/21 Piper Sandler
Gilead pact with Merck can bring HIV sustainability, says Piper Sandler
MEDP Medpace
$171.71 /

+0.78 (+0.46%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

ORTX Orchard Therapeutics
$7.09 /

-0.14 (-1.94%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

MEDP Medpace
$171.71 /

+0.78 (+0.46%)

KRYS Krystal Biotech
$74.13 /

-4.6 (-5.84%)

IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FTV Fortive
$71.18 /

-0.78 (-1.08%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

FLXN Flexion
$8.71 /

-0.11 (-1.25%)

DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

DOV Dover
$139.44 /

-0.74 (-0.53%)

CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FTV Fortive
$71.18 /

-0.78 (-1.08%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

DOV Dover
$139.44 /

-0.74 (-0.53%)

DBTX Decibel Therapeutics
$11.48 /

+0.09 (+0.79%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 09:55
04/06/21
04/06
09:55
04/06/21
09:55
BLUE

Bluebird Bio

$30.45 /

-0.65 (-2.09%)

, GILD

Gilead

$66.10 /

-0.25 (-0.38%)

, TMO

Thermo Fisher

$465.69 /

+0.13 (+0.03%)

, SGTX

Sigilon Therapeutics

$20.04 /

+0.02 (+0.10%)

, ADAP

Adaptimmune

$5.58 /

-0.03 (-0.53%)

, AGTC

Applied Genetic

$4.95 /

-0.05 (-1.00%)

, ATRA

Atara Biotherapeutics

$14.68 /

+ (+0.00%)

, CABA

Cabaletta Bio

$11.61 /

+ (+0.00%)

, FLXN

Flexion

$8.65 /

-0.17 (-1.93%)

, DTIL

Precision BioSciences

$10.30 /

-0.17 (-1.62%)

, DOV

Dover

$140.45 /

+0.27 (+0.19%)

, GNPX

Genprex

$4.14 /

-0.09 (-2.13%)

, DBTX

Decibel Therapeutics

$11.36 /

-0.03 (-0.26%)

, CYRX

Cryoport

$50.71 /

+0.34 (+0.68%)

, GLW

Corning

$45.30 /

-0.19 (-0.42%)

, FTV

Fortive

$72.04 /

+0.08 (+0.11%)

, KRYS

Krystal Biotech

$78.76 /

+0.03 (+0.04%)

, NVO

Novo Nordisk

$68.09 /

-0.19 (-0.28%)

, NVS

Novartis

$87.06 /

-0.23 (-0.26%)

, ORTX

Orchard Therapeutics

$7.19 /

-0.04 (-0.55%)

, MRK

Merck

$76.44 /

-0.56 (-0.73%)

, MEDP

Medpace

$173.03 /

+2.1 (+1.23%)

, IOVA

Iovance Biotherapeutics

$31.80 /

-0.35 (-1.09%)

, FOLD

Amicus

$9.89 /

-0.055 (-0.55%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

ORTX Orchard Therapeutics
$7.19 /

-0.04 (-0.55%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

KRYS Krystal Biotech
$78.76 /

+0.03 (+0.04%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GNPX Genprex
$4.14 /

-0.09 (-2.13%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FTV Fortive
$72.04 /

+0.08 (+0.11%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

FLXN Flexion
$8.65 /

-0.17 (-1.93%)

DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

DOV Dover
$140.45 /

+0.27 (+0.19%)

DBTX Decibel Therapeutics
$11.36 /

-0.03 (-0.26%)

CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

ADAP Adaptimmune
$5.58 /

-0.03 (-0.53%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$66.10 /

-0.25 (-0.38%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$5.58 /

-0.03 (-0.53%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.65 /

-0.17 (-1.93%)

08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Credit Suisse
Flexion initiated with an Outperform at Credit Suisse
DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
12/15/20 H.C. Wainwright
Precision BioSciences transferred with Buy rating at H.C. Wainwright
DOV Dover
$140.45 /

+0.27 (+0.19%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.14 /

-0.09 (-2.13%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$11.36 /

-0.03 (-0.26%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$45.30 /

-0.19 (-0.42%)

01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
01/06/21
Fly Intel: Top five analyst initiations
FTV Fortive
$72.04 /

+0.08 (+0.11%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$78.76 /

+0.03 (+0.04%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$87.06 /

-0.23 (-0.26%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$7.19 /

-0.04 (-0.55%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$76.44 /

-0.56 (-0.73%)

04/01/21 Morgan Stanley
Merck cancer pipeline underappreciated and 'set to flow,' says Morgan Stanley
03/15/21 Piper Sandler
Gilead pact with Merck can bring HIV sustainability, says Piper Sandler
02/25/21 SVB Leerink
Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
MEDP Medpace
$173.03 /

+2.1 (+1.23%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.89 /

-0.055 (-0.55%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

ORTX Orchard Therapeutics
$7.19 /

-0.04 (-0.55%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

MEDP Medpace
$173.03 /

+2.1 (+1.23%)

KRYS Krystal Biotech
$78.76 /

+0.03 (+0.04%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FTV Fortive
$72.04 /

+0.08 (+0.11%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

FLXN Flexion
$8.65 /

-0.17 (-1.93%)

DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

DOV Dover
$140.45 /

+0.27 (+0.19%)

CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

ADAP Adaptimmune
$5.58 /

-0.03 (-0.53%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FTV Fortive
$72.04 /

+0.08 (+0.11%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

DOV Dover
$140.45 /

+0.27 (+0.19%)

DBTX Decibel Therapeutics
$11.36 /

-0.03 (-0.26%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.